Kainate receptors: An interplay between excitatory and inhibitory synapses

FEBS Letters

Volumn 430, Issue 1-2, 1998, Pages 100-104

  Lerma, Juan ^a  

^a INSTITUTO CAJAL   (Spain)

Author keywords

Epilepsy; GABA; GluR5; GluR6; Glutamate; Kainate

Indexed keywords

ANTICONVULSIVE AGENT; GLUTAMATE RECEPTOR; GLUTAMIC ACID; KAINIC ACID RECEPTOR;

CONFERENCE PAPER; EPILEPSY; GABAERGIC SYSTEM; HIPPOCAMPUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION; SYNAPTIC TRANSMISSION;

ANIMALS; RECEPTORS, KAINIC ACID; SYNAPSES;

EID: 0032560495     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(98)00462-1     Document Type: Conference Paper

References (47)

1. Hollmann M., Heinemann S.F. Annu. Rev. Neurosci. 17:1994;31-108.
2. Westbrook G.L. Curr. Opin. Neurobiol. 4:1994;337-346.
3. Lerma J., Morales M., Vicente M.A., Herreras O. Trends Neurosci. 20:1997;9-12.
4. Castillo P.E., Malenka R.C., Nicoll R.A. Nature. 388:1997;182-186.
5. Clarke V.R.J., Ballyk B.A., Hoo K.H., Mandelzys A., Pellizari A., Bath C.P., Thomas J., Sharpe E.F., Davies C.H., Ornstein P.L., Schoepp D.D., Kamboj R.K., Collingridge G.L., Lodge D., Bleakman D. Nature. 389:1997;599-602.
6. Rodríguez-Moreno A., Herreras O., Lerma J. Neuron. 19:1997;893-901.
7. Vignes M., Collingridge G.L. Nature. 388:1997;179-182.
8. Lerma J. Neuron. 19:1997;1155-1158.
9. Bettler B., Boulter J., Hermans-Borgmeyer I., O'Shea-Greenfield A., Deneris E.S., Moll C., Borgmeyer U., Hollmann M., Heinemann S. Neuron. 5:1990;583-595.
10. Sommer B., Burnashev N., Verdoorn T.O., Keinänen K., Sakmann B., Seeburg P.H. EMBO J. 11:1992;1651-1656.
11. Egebjerg J., Bettler B., Hermans-Borgmeyer I., Heinemann S. Nature. 351:1991;745-748.
12. Herb A., Burnashev N., Werner P., Sakmann B., Wisden W., Seeburg P.H. Neuron. 8:1992;775-785.
13. Schiffer H.H., Swanson G.T., Heinemann S.F. Neuron. 19:1997;1141-1146.
14. Seeburg P.H. J. Neurochem. 66:1996;1-5.
15. Burnashev N. Curr. Opin. Neurobiol. 6:1996;311-317.
16. Bahn, Volk, B. and Wisden, W. (1994) J. Neurosci. 14, 5525-5547.
17. Bischoff S., Barhanin J., Bettler B., Mulle C., Heinemann S. J. Comp. Neurol. 379:1997;541-562.
18. Good P.F., Morrison J.H. J. Comp. Neurol. 357:1995;25-35.
19. Petralia R.S., Wang Y.X., Wenthold R.J. J. Comp. Neurol. 349:1994;85-110.
20. Siegel S.J., Janssen W.G., Tullai J.W., Rogers S.W., Moran T., Henimann S.F., Morrison J.H. J. Neurosci. 15:1995;2702-2719.
21. Huettner J.E. Neuron. 5:1990;255-266.
22. Sailer A., Swanson T., Dyck R.H., Goda Y., O'Gorman S., Heinemann S.F. Soc. Neurosci. Abstr. 23:1997;922.
23. Lerma J., Paternain A.V., Naranjo J.R., Mellström B. Proc. Natl. Acad. Sci. USA. 90:1993;11688-11692.
24. Wilding T.J., Huettner J.E. J. Neurosci. 17:1997;2713-2721.
25. Patneau D.K., Wright P.W., Winters C., Mayer M.L., Gallo V. Neuron. 12:1994;357-371.
26. Ruano D., Lambolez B., Rossier J., Paternain A.V., Lerma J. Neuron. 14:1995;1009-1017.
27. Sahara Y., Noro N., Iida Y., Soma K., Nakamura Y. J. Neurosci. 17:1997;6611-6620.
28. Paternain A.V., Vicente M.A., Nielsen E.Ø., Lerma J. Eur. J. Neurosci. 8:1996;2129-2136.
29. Wilding T.J., Huettner J.E. Mol. Pharmacol. 49:1996;540-546.
30. Verdoorn T.A., Johansen T.H., Drejer J., Nielsen E.Ø. Eur. J. Pharmacol. (Mol. Pharmacol. Sect.). 269:1994;43-49.
31. Bleakmann D., Schoepp D.D., Ballyk B., Bufton H., Sharpe E., Thomas K., Ornstein P.L., Kamboj K. Mol. Pharmacol. 49:1996;581-585.
32. Bleakmann D., Ballyk B., Schoepp D.D., Palmer A.J., Bath K.P., Sharpe E., Wooley M.L., Bufton H., Kamboj K., Tarnawa I., Lodge D. Neuropharmacology. 35:1996;1689-1702.
33. Zhou L.-M., Gu Z.-Q., Costa A.M., Yamada K.A., Mansson P.E., Giordano T., Skolnick P., Jones K.A. J. Pharmacol. Exp. Ther. 280:1997;422-427.
34. Paternain A.V., Morales M., Lerma J. Neuron. 14:1995;185-189.
35. Mulle C., Sailer A., Perez-Otaño I., Dickinson-Anson H., Castillo P.E., Bureau I., Maron C., Gage F.H., Mann J.R., Bettler B., Heinemann S.F. Nature. 392:1998;601-605.
36. Chittajallu R., Vignes M., Dev K.K., Barnes J.M., Collingridge G.L., Henley J.M. Nature. 379:1996;78-81.
37. Cherubini E., Rovira C., Ben-Ari Y., Nistri A. Epilepsy Res. 5:1990;18-27.
38. Fisher R.S., Alger B.E. J. Neurosci. 4:1984;1312-1323.
39. Sloviter R.S., Damiano B.P. Neuropharmacology. 20:1981;1001-1011.
40. Westbrook G.L., Lothman E.W. Brain Res. 273:1983;97-109.
41. Sander T., Hildmann T., Kretz R., Fürst R., Sailer U., Bauer G., Schmitz B., Beck-Mannagetta G., Wienker T., Janz D. Am. J. Med. Genet. 74:1997;416-421.
42. Lerma J., Paternain A.P., Villarroel A. Soc. Neurosci. Abstr. 23:1997;1761.
43. Attwell D., Mobbs P. Curr. Opin. Neurobiol. 4:1994;353-359.
44. Benveniste H., Drejer J., Schousboe A., Diemer N.H. J. Neurochem. 43:1984;1369-1374.
45. Paternain, A.V., Rodríguez-Moreno, A., Villarroel, A. and Lerma, J. (1998) Neuropharmacology, in press.
46. Tanaka K., Waase K., Manabe T., Yamada K., Watanabe M., Takahashi K., Iwama H., Nishikawa T., Ichihara N., Kikuchi T., Okuyama S., Kawashima N., Hori S., Takimoto M., Wada K. Science. 276:1997;1699-1702.
47. Mayer M.L. Nature. 389:1997;542-543.